Factors Associated With Parental Observation of Side Effects Following the Child Flu Vaccine
NCT02909855 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270
Last updated 2018-08-09
Summary
This study investigates whether there are psychological predictors of parental perception of side-effects following vaccination with the child flu vaccine. We will also investigate whether the perception of side-effects affects parents' intention to vaccinate their child again in the following flu season, as well as whether there are underlying differences in parents' cognitive biases between those who do and do not re-vaccinate their child.
Conditions
- Influenza Vaccine, Influenza
Interventions
- OTHER
-
No intervention
Participants in this study will not receive any interventions as part of the study.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
G James Rubin, PhD · King's College London
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2017-01-31
- Completion
- 2018-05-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months
NCT00311428 ·Status: COMPLETED ·Phase: PHASE4
-
Childhood Influenza Immunisation in General Practice Invitation Trial
NCT02921633 ·Status: COMPLETED ·Phase: NA
-
Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England
NCT03278067 ·Status: COMPLETED
-
FeverText: Assessing Fever Rates After Vaccination During the 2011-12 Influenza Season Using Text Messaging
NCT01467934 ·Status: COMPLETED
-
Childhood Influenza Immunisation Invitation Trial in Schools
NCT02883972 ·Status: WITHDRAWN ·Phase: NA
-
Influenza Vaccine Safety and Effectiveness in Healthcare Providers
NCT01282177 ·Status: COMPLETED
-
A Study to Describe Pediatric Influenza Vaccine Coverage
NCT00639418 ·Status: COMPLETED
-
Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects
NCT00630331 ·Status: COMPLETED ·Phase: PHASE3
-
Attitudes Toward Human Papillomavirus and Influenza Vaccination Among Mothers of Early Adolescents
NCT02358083 ·Status: COMPLETED ·Phase: NA
-
Surveillance for Adverse Events Following Influenza Immunization
NCT01318876 ·Status: COMPLETED
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Subjects 18 Years of Age or Older
NCT00329966 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Influenza Vaccination in Pregnancy Video Education
NCT02151201 ·Status: COMPLETED ·Phase: NA
-
Direct and Indirect Benefits of Influenza Vaccination in Schools and Households
NCT00981513 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old
NCT00464672 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic and Environmental Factors in the Response to Influenza Vaccination
NCT03088904 ·Status: COMPLETED ·Phase: PHASE1
-
Surveillance for Adverse Events Following Pandemic H1N1 Immunization
NCT01289418 ·Status: COMPLETED
-
Influenza Vaccine in Children With Asthma
NCT04086628 ·Status: UNKNOWN
-
Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old
NCT01992107 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Flu Vaccine Doses in Children
NCT01164553 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Fever and Wheezing Events in Children After US Influenza Vaccines Using Text Messaging
NCT02295007 ·Status: COMPLETED ·Phase: NA
-
Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children
NCT00792051 ·Status: COMPLETED ·Phase: NA
-
Safety, Immunogenicity, and Relative Efficacy of H1N1 Vaccines in Adults Aged 18 Years and Older
NCT00979602 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Immunogenicity of Fluzone® Quadrivalent Vaccine Administered to Healthy Children
NCT02915302 ·Status: COMPLETED ·Phase: PHASE4
-
A/H5N1 Vaccine in Healthy Children Aged 2-9 Years
NCT00133536 ·Status: COMPLETED ·Phase: PHASE1/PHASE2